Introduction: Ventricular arrhythmia (VA) from the left ventricular summit (LVS) is a common origin of VA, which resulting LV dysfunction in some patients. However, the predictors of LV cardiomyopathy were not well-elucidated. The present study sought to investigate the risk factor of LV cardiomyopathy and the outcome in patients with LVS VA Methods: Between 2013 and 2018, a total of 139 patients (60.7% men; mean age 53.2 ± 13.9 years-old) underwent catheter ablation for LVS VA from two centers. Detailed patient demographics, electrocardiograms, electrophysiological characteristics, and clinical outcomes were extracted for analysis. LV cardiomyopathy was defined as LV ejection fraction (LVEF) <50%. Results: Acute procedural success was achieved in 92.8 % of patients. There were 40 patients (28.8%) with LV cardiomyopathy, and the mean LVEF improved from 37.5 ± 9.3% to 48.5 ± 10.2% after ablation ( p < 0.001). After multivariate analysis, the independent predictors of LV dysfunction were wider QRS duration of the VA (odds ratio [OR]1.02; 95% confidence interval [CI]: 1.00-1.04; p = 0.046) and the absolute earliest activation time discrepancy (AEAD) between epicardium and endocardium (OR 1.05; 95% confidence interval CI: 1.00-1.09; p = 0.048). After ablation, the LV function was completely recovered in 20 patients (50%). The predictors for irreclaimable LV function included wider PVC QRS duration (OR 1.09; 95% CI: 1.02-1.17; p = 0.012) and poorer LVEF (OR 0.85; 95% CI: 0.74-0.97; p = 0.020). Conclusion: In patients with VA from LVS, PVC QRS duration and AEAD predicted the deteriorating LV systolic function. Catheter ablation could reverse the LV remodeling. Narrower QRS duration and better LVEF predicted a better recovery of LV function after ablation.